close

Enter

Log in using OpenID

Europe Antivenom Market

embed
Europe Antivenom Market is expected to reach USD 340.3 million by 2021 from USD 264.0 million in 2016, growing at a CAGR of 5.21% during the forecast period 2016-2021.
Europe Antivenom Market is expected to reach USD 340.3 million by 2021 from USD 264.0 million in
2016, growing at a CAGR of 5.21% during the forecast period 2016-2021. Antivenom is described as the
biological product that detoxifies poisoning of venomous bites. Antivenom is prepared from the milking
venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites
result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing
problems, and other difficulties that may lead to death also. It is estimated that, approximately 15,00020,000 people die with snake bites annually in Europe. To overcome poisonous effects after venomous
bites the manufacturers developed number of Antivenom products including vaccines and
hyperimmune sera.
View Full Report @ http://www.marketdataforecast.com/market-reports/europe-antivenom-market1582/
Growing involvement of research institutes to support the development of effective antivenom
products, existence of established medical care system, and development of effective antivenom
products against multiple venomous animals are driving the growth Europe Antivenom Market.
However, stringent regulatories, high cost of the products, and limited accessibility of antivenom
products are restraining the growth Europe Antivenom Market.
Europe Market for Antivenom broadly categorized into type and animal. On the basis of type, Europe
Antivenom market is segmented into Vaccines and Hyperimmune Sera (Homologous & Heterologous).
Based on animal the market is segmented into Snakes, Scorpions, Spiders, and Others. Geographically,
Europe Antivenom market is segmented into United Kingdom, Germany, France, Italy, and Spain.
Key market players in the Antivenom market include Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG
(Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.),
Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine
Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India).
Free sample of the report is available @ http://www.marketdataforecast.com/marketreports/europe-antivenom-market-1582/request-sample
Market Segmentation
1) Type






Introduction
Vaccines
Hyperimmune Sera
 Homologous
 Heterologous
Growth Analysis, By type
Attractiveness Analysis, By Type
Market Share Analysis, By Type

Introduction
2) Animal







Snakes
Scorpions
Spiders
Others
Y-o-Y Growth Analysis, By Animal
Market Attractiveness Analysis, By Animal
Market Share Analysis, By Animal
Inquire before Buying at http://www.marketdataforecast.com/market-reports/europe-antivenommarket-1582/inquire
Reasons to buy Europe Anti-venom Market Research Report:
• Regional and country-level analysis and forecasts of the study market; providing Insights on the
geographical areas in which this industry is prospering
• Segment-level analysis on basis of product Type and Animal along with market size forecasts and y-o-y
estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their
impact on shifting market dynamics
• Study of macro and micro environmental factors that affect the market presented in an extensive
strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
• A comprehensive listing of key market players along with company overview, product portfolios, key
financial information (subjected to availability), SWOT analysis and Analyst overview to study and
sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along
with new product launches, comparative financial studies and recent developments in the market by the
major companies
• Expertly devised Market Outlook along with Investment opportunities to provide both individuals and
organizations a strong financial foothold in the market
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With
rich experience in research across various business domains, they cater to the needs of both individual
and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets
covering all the major regions across the globe as part of the research scope, their research services
offer one of a kind specialties with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: [email protected]
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Author
Bhargav
Bhargav410   documents Email
Document
Category
Business and Leadership
Views
6
File Size
497 KB
Tags
Europe Antivenom Market, market, Antivenom Market
1/--pages
Report inappropriate content